51391-96-9

51391-96-9 structure

Name: CMC·HCI
Chemical Name: 2-(hydroxymethyl)-6-imino-7-methyl-2,3,3a,9a-tetrahydrofuro[1,2][1,3]oxazolo[3,4-a]pyrimidin-3-ol,hydrochloride
CAS Number: 51391-96-9
Molecular Formula: C₁₀H₁₄ClN₃O₄
Molecular Weight: 275.69
Catalog: Signaling Pathways Cell Cycle/DNA Damage Nucleoside Antimetabolite/Analog
Create Date: 2018-07-30 20:02:15
Modify Date: 2024-01-16 14:13:15
5-Methylcyclocytidine hydrochloride is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

Name	2-(hydroxymethyl)-6-imino-7-methyl-2,3,3a,9a-tetrahydrofuro[1,2][1,3]oxazolo[3,4-a]pyrimidin-3-ol,hydrochloride
Synonyms	I07-0083 6H-Furo[2',3':4,5]oxazolo[3,2]pyrimidine-2-methanol,2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-7-methyl-,monohydrochloride,[2R-(2a,3b,3ab)]-(9Cl)

Description	5-Methylcyclocytidine hydrochloride is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Cell Cycle/DNA Damage >> Nucleoside Antimetabolite/Analog
References	[1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.

Hazard Codes	Xn